AlphaFold predicted structure
TK2 · O00142

Mean pLDDT
84.7/ 100
Confident
265 residues
Confidence breakdown
- Very high(≥ 90)73%
- Confident(70–90)6%
- Low(50–70)3%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
thymidine kinase 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalMitochondrial DNA maintenance disorder
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalRhabdomyolysis and metabolic muscle disorders
BIALLELIC, autosomal or pseudoautosomal+8 more panels — install the extension to see the full list inline on any page.
mitochondrial DNA depletion syndrome, myopathic form
progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 3
mitochondrial disease
autosomal recessive progressive external ophthalmoplegia
mitochondrial DNA depletion syndrome
neurodegenerative disease
hereditary disease
inborn mitochondrial metabolism disorder
myopathy
Abnormality of the musculature
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Thymidine kinase 2, mitochondrial
Phosphorylates thymidine, deoxycytidine, and deoxyuridine in the mitochondrial matrix (PubMed:11687801, PubMed:9989599). In non-replicating cells, where cytosolic dNTP synthesis is down-regulated, mtDNA synthesis depends solely on TK2 and DGUOK (PubMed:9989599). Widely used as target of antiviral and chemotherapeutic agents (PubMed:9989599)
TK2 · O00142

Mean pLDDT
84.7/ 100
Confident
265 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0